Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Treatments for melanin disorders exist, but more effective options needed.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

The new method improves skin cancer detection in imbalanced datasets.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Prolactin slows down hair growth in mice.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Acne is the most common skin problem in Brazil, with a need for improved dermatological care and health education, especially for the public sector and black-skinned individuals.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Psoriasis can cause temporary or permanent hair loss.